Cargando…
DIPG-46. TARGETING THE METABOLIC ERK5-PFKFB3 AXIS IN PEDIATRIC DIFFUSE MIDLINE GLIOMA
Diffuse midline glioma is an aggressive brain tumor with a median age at diagnosis of 6.3 years and 5-year survival rate of 2.2%.The defining histone mutation H3K27M precludes docking of a protein responsible for epigenetic modification resulting in erroneously accessible chromatin and subsequent tr...
Autores principales: | Casillo, Stephanie, Gatesman, Taylor, Chilukuri, Akanksha, Jane, Esther, Premkumar, Daniel, Barber, Callie, Halbert, Matthew, Cruz, Andrea, Mullett, Steven, Michel, Joshua, Chang, Yue-Fang, MichaelRaj, Antony, Lieberman, Frank, Felker, James, Shiva, Sruti, Abdullah, Kalil, Zinn, Pascal, Friedlander, Robert, Abel, Taylor, Venneti, Sriram, Mack, Stephen, Wendell, Stacy, Pollack, Ian, Agnihotri, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260195/ http://dx.doi.org/10.1093/neuonc/noad073.093 |
Ejemplares similares
-
DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16
por: Chilukuri, Akanksha, et al.
Publicado: (2023) -
DIPG-48. DIPG THROUGH THE LOOKING GLASS
por: Senga, Sasi S
Publicado: (2023) -
DIPG-39. SIGNALING NETWORKS IN PEDIATRIC-TYPE DIFFUSE HIGH GRADE GLIOMAS
por: Herbst, Sophie A, et al.
Publicado: (2023) -
DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION
por: Liu, Ilon, et al.
Publicado: (2023) -
DIPG-05. EVALUATION OF TELOMERE-MODIFYING COMPOUND THIO AS A RADIOSENSITIZER AND IMMUNOMODULATOR TO TREAT DIPG
por: Mishra, Deepak, et al.
Publicado: (2023)